What is IRMD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.98B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for IRMD?

P/E (TTM) is 42.53 and 52-week range is $75.75 to $107.90 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s IRMD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for IRMD?

The company profile lists revenue (TTM) near $86M, net income (TTM) near $23M, EPS (TTM) near $1.79 when available from the market-data feed. Figures are informational and may lag live markets.

Does IRMD show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $1.24, yield near 1.61%, ex-dividend date Aug 14, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is IRADIMED CORPORATION based, and what identifiers does Chartloom list?

The company context section lists headquarters in Orlando, Florida, US, 12.8M shares outstanding, ISIN US46266A1097 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

IRADIMED CORPORATION

$IRMD

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.

Employees

166

Website

www.iradimed.com/

IPO

2014-07-16

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US46266A1097

Headquarters

Orlando, Florida, US

Shares outstanding

12.8M

NAICS sector

Manufacturing

Institutional ownership

62.70%

Browse other companiesFree AI scores and summaries for more stocks